Abbott Laboratories

Abbott Laboratories

Yahoo Finance • 17 hours ago

Abbott Laboratories (ABT) Posted Positive Trial Results For Two Heart Devices

Abbott Laboratories (NYSE:ABT) reported positive one year VERITAS trial outcomes for its Amulet 360 device in atrial fibrillation patients. The Amulet 360 Left Atrial Appendage Occluder showed high safety and efficacy for stroke risk reduc... Full story

Yahoo Finance • 19 hours ago

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer

DALLAS & OSS, Netherlands, November 04, 2026--(BUSINESS WIRE)--Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulat... Full story

Yahoo Finance • 2 days ago

Biosensors - Global Strategic Business Report: Secure Share of the $53.7 Billion Market by 2030 as Abbott, Dexcom, Medtronic and Masimo Accelerate Wearable and AI Diagnostics

Company Logo Capitalize on demand for wearable, point-of-care biosensors driven by chronic disease monitoring, nanotechnology, personalized medicine, and food and environmental safety. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biosensor... Full story

Yahoo Finance • 2 days ago

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026

BridgeBio Pharma, Inc. PALO ALTO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines... Full story

Yahoo Finance • 2 days ago

Should Retail Leadership Reset Require Action From Marzetti (MZTI) Investors?

Marzetti recently named Mark Christenson as President of its Retail business and promoted Rene Luichinger to Chief Customer Officer, assigning them responsibility for sales, marketing, innovation and customer strategy across its branded an... Full story

Yahoo Finance • 2 days ago

39 New Companies Join the 2026 Fortune Best Companies to Work For Southeast Asia List

Nearly two in five companies on this year's list are first-time entrants. DHL Group stays at No. 1. SINGAPORE, Nov. 3, 2026 /PRNewswire/ -- Fortune and Great Place To Work today named the 2026 Fortune Best Companies to Work For Southeast... Full story

Yahoo Finance • 3 days ago

Abbott Touts Favorable Outcomes In Cardiovascular Device Trials

Abbott Laboratories(NYSE:ABT) reported positive clinical trial results for two investigational cardiovascular devices at the Transcatheter Cardiovascular Therapeutics conference in San Diego, demonstrating high procedural success and low c... Full story

Yahoo Finance • 3 days ago

Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke

Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions; data show the device achieved high closure rates of... Full story

Yahoo Finance • 3 days ago

HSS Medical Supply Announces Distributor Agreement for Abbott's ID NOW Rapid Molecular Testing Platform

NEW YORK, Nov. 2, 2026 /PRNewswire/ -- One of the fastest-growing healthcare suppliers, HSS Medical Supply, announced a new vendor agreement with Abbott. The family-owned distribution company now includes Abbott's ID NOW™, a rapid molecula... Full story

Yahoo Finance • 3 days ago

Capital Power reports third quarter 2026 results

Capital Power Corporation EDMONTON, Alberta, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended September 30, 2026. Highlights Long-term Energy Supply Agreement... Full story

Yahoo Finance • 3 days ago

Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up kidney stones, to crack calcium in coronary arteries and restore blood flow The system is... Full story

Yahoo Finance • 5 days ago

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picks

The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) closed in the red on Friday, after investors digested corporate results from... Full story

Yahoo Finance • 6 days ago

Can Abbott Laboratories (ABT) Stay Reasonable As Its Breakup Nears?

Abbott Laboratories has seen a mixed share price record in recent years, which raises a straightforward question for anyone following the stock: Are the cash flows that Abbott can generate over time enough to justify where the shares trade... Full story

Yahoo Finance • 6 days ago

Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN

Company Logo Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Human Papillomavirus (HPV) Genotyping Panels Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global human papillomavirus (HPV) genotyping panels... Full story

Yahoo Finance • 6 days ago

Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes Off

Dexcom, known for its G-series of diabetes wearables, topped September-quarter expectations late Thursday, leading to a guidance hike. Continue Reading... Full story

Yahoo Finance • 7 days ago

South & Central America Point of Care Diagnostics Market Size, Share, Trends and Forecast (2026-2031) Featuring Profiles of Siemens, Abbott Labs, Roche, bioMerieux, Bio-Rad Labs and More

Company Logo Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "South & Central America Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis" has been added to ResearchAndMarkets... Full story

Yahoo Finance • 7 days ago

Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease

CROWN-MV trial will evaluate the safety and effectiveness of investigational Cephea mitral valve replacement device Abbott's Cephea is designed to provide a new, minimally invasive option for treating mitral valve disease, the most common... Full story

Yahoo Finance • 7 days ago

Apple Stock And Other Quality Growth Names For Higher Rates

The Fed just kept rates at 3.75% to 4% and still sounds ready to tighten further, which puts quality growth stocks back under a very sharp spotlight. In a market where inflation worries, data surprises and policy twists can quickly punish... Full story

Yahoo Finance • 8 days ago

What Could Abbott Laboratories (ABT) Spin Off Mean For Its Future Growth?

Abbott Laboratories (NYSE:ABT) plans to separate its Nutrition segment into an independent publicly traded company, targeting completion after regulatory and internal approvals. The Nutrition division, which records about US$8.5b in annual... Full story

Yahoo Finance • 8 days ago

Europe Medical Foods Market Size, Share, Trends and Strategic Outlook, 2026-2033 Featuring Danone, Nestle, Abbott, Targeted Medical Pharma, Primus Pharma, Fresenius Kabi, Mead Johnson & Co.

Company Logo Capitalize on Europe's aging population and chronic disease burden with specialized nutrition, channel-focused expansion and actionable country-level insights Dublin, Oct. 28, 2026 (GLOBE NEWSWIRE) -- "Europe Medical Foods M... Full story